|Day Low/High||1.05 / 1.27|
|52 Wk Low/High||4.08 / 15.01|
NeuroDerm, Novavax and Nektar Therapeutics were among the biotech stock movers in premarket trading on July 24.
- Announce topline data from the Phase 2 Safety and Immunogenicity trial of the RSV F Vaccine in older adults
The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 7,426,054 share decrease in total short interest for Novavax, Inc. , to 56,851,825, a decrease of 11.55% since 06/15/2017.
Alexion, Arena and Novavax were among the biotech stock movers ahead of the market open on Friday, July 7.
Pacific Biosciences of California, AveXis and Novavax were among the biotech stock movers in premarket trading on Thursday.
Investors are in full wait and see mode.
Stocks wade further into the green on Wednesday afternoon after former FBI director James Comey's prepared testimony is made public.
Stocks move cautiously higher as investors wait for direction from a number of market-churning events tomorrow.
Stocks move cautiously higher on Wednesday as investors wait for direction from a number of market-churning events on Thursday and a major selloff in crude kneecaps indexes.
Stock futures are in a holding pattern again on Wednesday as investors cautiously wait for direction from a number of market-churning events on Thursday.
Trial demonstrated a reduction of RSV infection in vaccinated women of greater than 50%, suggesting potential benefits to the mother, pregnancy outcomes and her infant
Akebia Therapeutics, Editas Medicine and Novavax were among the biotech movers in premarket trading on Tuesday.
Sarepta Therapeutics, Bellicum Pharmaceuticals and Novavax were among the biotech stock movers in premarket trading on Wednesday.
Here's a technical look at how to trade several under-$10 stocks that could break out soon.
Cempra, Novavax and Ionis Pharmaceuticals were among the biotech stock movers in premarket trading on Tuesday.
In addition to Sage Therapeutics, also moving biotech Friday: Novavax, Cytokinetics and Acadia Pharmaceuticals.
Amicus Therapeutics, Nantkwest and Organovo are among the premarket biotech movers on Tuesday.
Investors eyeing a purchase of Novavax, Inc. stock, but tentative about paying the going market price of $1.32/share, might benefit from considering selling puts among the alternative strategies at their disposal.